Vital Healthcare Property Trust (NZSE:VHP) Research & Development: NZ$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:VHP Vital Healthcare Property Trust NZSE:VHP
75 GF Score
Price NZ$1.90
GF Value NZ$1.76
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Vital Healthcare Property Trust Research & Development?

Vital Healthcare Property Trust NZSE:VHP +0.53% 75 Research & Development is NZ$0.0 Mil as of Dec. 2025. GuruFocus rates NZSE:VHP with a GF Score™ of 75/100 and a GF Value™ of NZ$1.76 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Vital Healthcare Property Trust's Research & Development for the six months ended in Dec. 2025 was NZ$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$0.0 Mil.

Vital Healthcare Property Trust  (NZSE:VHP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Vital Healthcare Property Trust Research & Development Related Terms

Vital Healthcare Property Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Vital Healthcare Property Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital Healthcare Property Trust Research & Development Chart

Vital Healthcare Property Trust Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vital Healthcare Property Trust Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NZSE:VHP
75GF Score
Vital Healthcare Property Trust NZSE:VHP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital Healthcare Property Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NZ$0.0 Mil mean?
Vital Healthcare Property Trust (NZSE:VHP) has a Research & Development of NZ$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Vital Healthcare Property Trust and its competitors.
Is Vital Healthcare Property Trust's Research & Development too high?
Vital Healthcare Property Trust's current Research & Development is NZ$0.0 Mil. Overall, Vital Healthcare Property Trust has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vital Healthcare Property Trust's Research & Development compare to WELL and VTR?
Vital Healthcare Property Trust's Research & Development of NZ$0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Vital Healthcare Property Trust and its competitors. Vital Healthcare Property Trust's current Research & Development is NZ$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital Healthcare Property Trust stock overvalued right now?
Based on GuruFocus' analysis, Vital Healthcare Property Trust (NZSE:VHP) is currently considered Fairly Valued. The stock's GF Value™ is NZ$1.76, compared to a current price of NZ$1.90 — trading 8% above its estimated fair value. The current Research & Development is NZ$0.0 Mil. Vital Healthcare Property Trust's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Vital Healthcare Property Trust (NZSE:VHP), the current Research & Development is NZ$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital Healthcare Property Trust (NZSE:VHP) Overvalued in 2026?

Based on GuruFocus' analysis, Vital Healthcare Property Trust stock appears to be overvalued. The current stock price of NZ$1.90 is trading 8% above its estimated GF Value™ of NZ$1.76. GuruFocus considers Vital Healthcare Property Trust to be Fairly Valued.

Key valuation signals for NZSE:VHP:

  • Research & Development: NZ$0.0 Mil
  • GF Value™: NZ$1.76 vs. price of NZ$1.90 (8% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the NZSE:VHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vital Healthcare Property Trust Business Description

Industry Real EstateREITs
Address 188 Quay Street, Level 17, HSBC Tower, Auckland, NTL, NZL, 1010
Vital Healthcare Property Trust is a healthcare REIT. The vast majority of revenue is generated in Australia, followed by New Zealand. Majority of the company's tenants are for-profit hospitals, followed by medical consultants and nonprofit hospitals. The company's principal activity is the investment in, and management of, high quality real estate in good locations used by healthcare operators or used for healthcare, life sciences and related purposes. It operates in Australia and New Zealand.
75GF Score

Get the complete analysis for NZSE:VHP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$1.90
Price
NZ$1.76
GF Value